SCIO Scios Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SCIO Scios Inc.

SCIO 0.01000

0.0%

Aug 19 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who wrote (1436)	7/17/2002 6:45:49 PM
From: quidditch	Read Replies (1) of 1477

Rick, if I recall accurately SCIO's Q1 CC, management said that it was going to get a peek at toxicity indications in the current trial of SCIO 469 in the latter half of July. I believe that the same person on the call also said that there were not going to be any mid-trial efficacy indications. It seems likely that SCIO will disclose this anecdotal information at next week's meeting. (I may have it backward as to whether efficacy indications were to be revealed, but I don't think so.) quid

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next